The role of dendritic cell subsets in immunity to viruses

Current Opinion in Immunology

Volumn 15, Issue 4, 2003, Pages 416-420

  Carbone, Francis R ^a   Heath, William R ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ACTIVITY; CELL FUNCTION; CELL SUBPOPULATION; CELL TYPE; CELLULAR IMMUNITY; CYTOLOGY; DENDRITIC CELL; HUMAN; NONHUMAN; PATHOGENESIS; REVIEW; VIRUS INFECTION;

EID: 0042905869     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(03)00074-8     Document Type: Review

References (51)

1. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature. 392:1998;245-252.
2. Bhardwaj N. Interactions of viruses with dendritic cells: a double-edged sword. J. Exp. Med. 186:1997;795-799.
3. Sevilla N., Kunz S., Holz A., Lewicki H., Homann D., Yamada H., Campbell K.P., de La Torre J.C., Oldstone M.B. Immunosuppression and resultant viral persistence by specific viral targeting of dendritic cells. J. Exp. Med. 192:2000;1249-1260.
4. Fugier-Vivier I., Servet-Delprat C., Rivailler P., Rissoan M.C., Liu Y.J., Rabourdin-Combe C. Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells. J. Exp. Med. 186:1997;813-823.
5. Shortman K., Liu Y.J. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2:2002;151-161 This is an excellent review that provides a comprehensive and extensive description of the different dendritic cell subsets.
6. Cella M., Jarrossay D., Facchetti F., Alebardi O., Nakajima H., Lanzavecchia A., Colonna M. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat. Med. 5:1999;919-923.
7. Rissoan M.C., Soumelis V., Kadowaki N., Grouard G., Briere F., de Waal Malefyt R., Liu Y.J. Reciprocal control of T helper cell and dendritic cell differentiation. Science. 283:1999;1183-1186.
8. Vremec D., Zorbas M., Scollay R., Saunders D.J., Ardavin C.F., Wu L., Shortman K. The surface phenotype of dendritic cells purified from mouse thymus and spleen: investigation of the CD8 expression by a subpopulation of dendritic cells. J. Exp. Med. 176:1992;47-58.
9. Ardavin C., Wu L., Li C.L., Shortman K. Thymic dendritic cells and T cells develop simultaneously in the thymus from a common precursor population. Nature. 362:1993;761-763.
10. Anjuere F., Martin P., Ferrero I., Fraga M.L., del Hoyo G.M., Wright N., Ardavin C. Definition of dendritic cell subpopulations present in the spleen, Peyer's patches, lymph nodes, and skin of the mouse. Blood. 93:1999;590-598.
11. Henri S., Vremec D., Kamath A., Waithman J., Williams S., Benoist C., Burnham K., Saeland S., Handman E., Shortman K. The dendritic cell populations of mouse lymph nodes. J. Immunol. 167:2001;741-748.
12. Manz M.G., Traver D., Miyamoto T., Weissman I.L., Akashi K. Dendritic cell potentials of early lymphoid and myeloid progenitors. Blood. 97:2001;3333-3341.
13. + DC1 precursors. Blood. 101:2003;1453-1459.
14. + cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells. J. Exp. Med. 194:2001;1171-1178.
15. Asselin-Paturel C., Boonstra A., Dalod M., Durand I., Yessaad N., Dezutter-Dambuyant C., Vicari A., O'Garra A., Biron C., Briere F.et al. Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat. Immunol. 2:2001;1144-1150.
16. Muller U., Steinhoff U., Reis L.F., Hemmi S., Pavlovic J., Zinkernagel R.M., Aguet M. Functional role of type I and type II interferons in antiviral defense. Science. 264:1994;1918-1921.
17. Fitzgerald-Bocarsly P. Human natural interferon-α producing cells. Pharmacol. Ther. 60:1993;39-62.
18. Siegal F.P., Kadowaki N., Shodell M., Fitzgerald-Bocarsly P.A., Shah K., Ho S., Antonenko S., Liu Y.J. The nature of the principal type 1 interferon-producing cells in human blood. Science. 284:1999;1835-1837.
19. Gilliet M., Boonstra A., Paturel C., Antonenko S., Xu X.L., Trinchieri G., O'Garra A., Liu Y.J. The development of murine plasmacytoid dendritic cell precursors is differentially regulated by FLT3-ligand and granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 195:2002;953-958.
20. Dalod M., Salazar-Mather T.P., Malmgaard L., Lewis C., Asselin-Paturel C., Briere F., Trinchieri G., Biron C.A. Interferon α/β and interleukin 12 responses to viral infections: pathways regulating dendritic cell cytokine expression in vivo. J. Exp. Med. 195:2002;517-528.
21. Barchet W., Cella M., Odermatt B., Asselin-Paturel C., Colonna M., Kalinke U. Virus-induced interferon α production by a dendritic cell subset in the absence of feedback signaling in vivo. J. Exp. Med. 195:2002;507-516.
22. Trobonjaca Z., Leithauser F., Moller P., Schirmbeck R., Reimann J. Activating immunity in the liver. I. Liver dendritic cells (but not hepatocytes) are potent activators of IFN-γ release by liver NKT cells. J. Immunol. 167:2001;1413-1422.
23. + T cells in vivo. J. Immunol. 170:2003;2540-2548.
24. Gerosa F., Baldani-Guerra B., Nisii C., Marchesini V., Carra G., Trinchieri G. Reciprocal activating interaction between natural killer cells and dendritic cells. J. Exp. Med. 195:2002;327-333.
25. Ferlazzo G., Tsang M.L., Moretta L., Melioli G., Steinman R.M., Munz C. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J. Exp. Med. 195:2002;343-351.
26. Piccioli D., Sbrana S., Melandri E., Valiante N.M. Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J. Exp. Med. 195:2002;335-341.
27. + dendritic cell subset.
28. Cavanaugh V.J., Deng Y., Birkenbach M.P., Slater J.S., Campbell A.E. Vigorous innate and virus-specific cytotoxic T-lymphocyte responses to murine cytomegalovirus in the submaxillary salivary gland. J. Virol. 77:2003;1703-1717.
29. + dendritic cells only after microbial stimulus. J. Exp. Med. 196:2002;1307-1319.
30. Lenz L.L., Butz E.A., Bevan M.J. Requirements for bone marrow-derived antigen-presenting cells in priming cytotoxic T cell responses to intracellular pathogens. J. Exp. Med. 192:2000;1135-1142.
31. Sigal L.J., Rock K.L. Bone marrow-derived antigen-presenting cells are required for the generation of cytotoxic T lymphocyte responses to viruses and use transporter associated with antigen presentation (TAP)-dependent and -independent pathways of antigen presentation. J. Exp. Med. 192:2000;1143-1150.
32. + dendritic cells to selectively deplete this subset and show that they were involved in CTL priming to intracellular pathogens.
33. Norbury C.C., Malide D., Gibbs J.S., Bennink J.R., Yewdell J.W. Visualizing priming of virus-specific CD8+ T cells by infected dendritic cells in vivo. Nat Immunol. 3:2002;265-271 This study is the first to show a direct interaction between virus-infected dendritic cells and antigen-specific T cells in situ during CTL priming.
34. Zinkernagel R.M. On cross-priming of MHC class I-specific CTL: rule or exception? Eur. J. Immunol. 32:2002;2385-2392.
35. Norbury C.C., Sigal L.J. Cross priming or direct priming: is that really the question? Curr. Opin. Immunol. 15:2003;82-88.
36. Heath W.R., Carbone F.R. Cross-presentation in viral immunity and self-tolerance. Nat Rev. Immunol. 1:2001;126-134.
37. Sigal L.J., Crotty S., Andino R., Rock K.L. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen. Nature. 398:1999;77-80.
38. + CTL following exposure to vaccinia virus via different routes. J. Immunol. 169:2002;4222-4229 These authors used a recombinant vaccinia virus bearing the US11 gene that inhibits endogenous MHC class I-restricted presentation to discriminate between direct and indirect presentation during CTL priming.
39. Ramirez M.C., Sigal L.J. Macrophages and dendritic cells use the cytosolic pathway to rapidly cross-present antigen from live, vaccinia-infected cells. J. Immunol. 169:2002;6733-6742 These authors used an elegant approach that required a virus-induced trans-activated antigen expression system to show cross-presentation by dendritic cells.
40. Mueller S.N., Jones C.M., Smith C.M., Heath W.R., Carbone F.R. Rapid cytotoxic T lymphocyte activation occurs in the draining lymph nodes after cutaneous herpes simplex virus infection as a result of early antigen presentation and not the presence of virus. J. Exp. Med. 195:2002;651-656.
41. Smith CM, Belz GT, Wilson NS, Villadangos JA, Shortman K, Carbone FR, Heath WR: Cutting Edge: Conventional CD8alpha(+) Dendritic Cells Are Preferentially Involved in CTL Priming After Footpad Infection with Herpes Simplex Virus-1. J Immunol 2003, 170:4437-4440.
42. + T cells and subsequently express CD8α and CD205 molecules. J. Exp. Med. 195:2002;1233-1245.
43. - dendritic cells cross-prime cytotoxic T cells in vivo. J. Exp. Med. 192:2000;1685-1696.
44. Belz G.T., Behrens G.M., Smith C.M., Miller J.F., Jones C., Lejon K., Fathman C.G., Mueller S.N., Shortman K., Carbone F.R.et al. The CD8alpha(+) dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens. J. Exp. Med. 196:2002;1099-1104.
45. + dendritic cells selectively take up antigen from dying cells for class I-restricted cross-presentation, which potentially explains their selective involvement in this event.
46. - dendritic cells in vivo. J. Exp. Med. 196:2002;817-827.
47. + dendritic cells. J. Immunol. 166:2001;5327-5330.
48. + T cells. Int. Immunol. 13:2001;465-473.
49. Zhao X., Deak E., Soderberg K., Linehan M., Spezzano D., Zhu J., Knipe D.M., Iwasaki A. Vaginal submucosal dendritic cells, but not langerhans cells, induce protective Th1 responses to herpes simplex virus-2. J. Exp. Med. 197:2003;153-162 This study examined dendritic cell involvement in helper T cell priming during vaginal infection and makes the surprising point that this event does not involve the major dendritic cell population in the mucosa.
50. King N.J., Parr E.L., Parr M.B. Migration of lymphoid cells from vaginal epithelium to iliac lymph nodes in relation to vaginal infection by herpes simplex virus type 2. J. Immunol. 160:1998;1173-1180.
51. + dendritic cells and antigen-specific CD4 T cells after subcutaneous injection of antigen. J. Immunol. 169:2002;2247-2252 These authors identify the major dendritic cell subset involved in helper T cell activation by examining dendritic cell-T cell interactions in situ.